Perbak Capital Partners’s Elanco Animal Health ELAN Stock Holding History

Perbak Capital Partners’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-494,432	Closed	-$9.96M	–	255
2025 Q3	$9.96M	Buy	494,432 +213,932	+76%	+$3.58M	1.75%	9
2025 Q2	$4.01M	Buy	+280,500	New	+$3.28M	0.91%	18
2025 Q1	–	Sell	-222,240	Closed	-$2.69M	–	197
2024 Q4	$2.69M	Buy	+222,240	New	+$2.91M	1.44%	16
2024 Q3	–	Sell	-332,250	Closed	-$4.79M	–	39
2024 Q2	$4.79M	Buy	+332,250	New	+$5.31M	1.42%	18

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Perbak Capital Partners's ELAN Position: Q4 2025 in Review

Perbak Capital Partners sold out of Elanco Animal Health (ELAN) in Q4 2025, closing a stake of 494,432 shares — an estimated $9.96M sold.

Perbak Capital Partners first reported a position in ELAN in Q2 2024 and held it in 4 quarters. The position peaked at $9.96M in Q3 2025. 485 funds tracked by Wall St. Rank hold ELAN as of Q4 2025.

Perbak Capital Partners reported no remaining Elanco Animal Health position as of Q4 2025 after selling out during the quarter.
Perbak Capital Partners sold 494,432 Elanco Animal Health shares in Q4 2025, an estimated $9.96M.
Perbak Capital Partners first reported a position in Elanco Animal Health in Q2 2024 and held it in 4 quarters.
Perbak Capital Partners's Elanco Animal Health position peaked at $9.96M in Q3 2025.
485 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2025.

Based on Perbak Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.